Accunea Ltd

Accunea is a point-of-care diagnostics company which is developing RenoSure, a medical device capable of detecting critical changes in transplant organ function in real-time, both before and after transplantation. This will enable closer monitoring of kidney transplant patients both pre- and post-operatively to ensure every patient receives a kidney in the best possible condition, and recovers without complications. RenoSure is assisted by AI software which enables early warnings from trend analysis, as well as enabling anonymised data aggregation and analytics for both individual and population-level health.